DF/BWCC now creates a precise “tumor profile” of genomic changes that helps physicians more accurately diagnose the subtype of a patient’s cancer, predict its behavior and help select precisely targeted therapy

Jeff was diagnosed with advanced lung cancer that had spread to his brain. His tumor tested positive for the ALK gene translocation so his treatment changed from chemotherapy to a targeted therapy that was more effective and had fewer side effects. Four years later, Jeff is still doing well.